Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Mar 26:27:100745.
doi: 10.1016/j.ymgmr.2021.100745. eCollection 2021 Jun.

Pregnancy in an adolescent with maple syrup urine disease: Case report

Michelle E Abadingo  1   2   3 , Mary Ann R Abacan  1   2 , Jeanne Ruth U Basas  2 , Carmencita D Padilla  1   2   3
Affiliations
Case Reports

Pregnancy in an adolescent with maple syrup urine disease: Case report

Michelle E Abadingo et al. Mol Genet Metab Rep. .

Abstract

Maple syrup urine disease (MSUD, MIM #248600) is an autosomal recessive metabolic disorder that results in elevation of the branched-chain amino acids (BCAA) leucine, isoleucine, and valine. Elevation of BCAA and certain alpha keto-acids is associated with a catabolic state and may result in neurological and developmental delays, feeding problems, and a urine and cerumen odor of maple syrup. Pregnancy is a period of multiple adaptations necessary to support fetal growth and development. Both the third trimester of pregnancy and the postpartum period present the possibility for catabolic states. We describe our treatment of an adolescent patient with intermittent MSUD and her resulting positive pregnancy outcome.

Keywords: Catabolic state; MSUD; Pregnancy.

PubMed Disclaimer

Conflict of interest statement

There are no financial conflicts of interest to disclose. There are no competing interests to disclose.

Figures

Fig. 1
Fig. 1
Overview of the BCAA catabolic pathway. BCAA leucine, isoleucine, and valine undergo transamination that is catalyzed by branched-chain aminotransferase (BCAT). This reaction requires α-Ketoglutarate, leading to the production of α-ketoacids α-ketoisocaproic acid (KIC), α-keto-β-methylvaleric acid (KMV), and α-ketoisovaleric acid (KIV). These intermediates undergo oxidative decarboxylation, catalyzed by the branched-chain α-ketoacid dehydrogenase (BCKAD) complex. Figure reprinted from Blackburn PR, Gass JM, Pinto e Vairo F, Farnham KM, Atwal HK, Macklin S et al. Maple syrup urine disease: mechanisms and management. Appl Clin Genet. 2017; 10: 57–66. This figure has been reproduced with permission from Dove Medical Press.
See this image and copyright information in PMC

References

    1. Blackburn P.R., Gass J.M., Vairo F.P. Maple syrup urine disease: mechanisms and management. Appl. Clin. Genet. 2017;10:57–66. doi: 10.2147/TACG.S125962. - DOI - PMC - PubMed
    1. Chuang D.T., Shih V.E. Maple syrup urine disease (Branched-chain ketoaciduria) In: Scriver C.R., editor. The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill; New York: 2001. pp. 1971–2006.
    1. Manoli I., Venditti C.P. Disorders of branched chain amino acid metabolism. Transl. Sci. Rare Dis. 2016;1:91–110. doi: 10.3233/TRD-160009. - DOI - PMC - PubMed
    1. Axler O., Holmquist P. Intermittent maple syrup urine disease: two case reports. Pediatrics. 2014;133(2):e458–e460. doi: 10.1542/peds.2013-0427. - DOI - PubMed
    1. Padilla C.D. Enhancing case detection of selected inherited disorders through expanded newborn screening in the Philippines. Acta Med. Philipp. 2013;47(1):24–29. doi: 10.47895/amp.v47i1.1429. - DOI

Publication types

LinkOut - more resources